120 results on '"Liver steatosis"'
Search Results
2. Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction
3. Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis
4. Multi-layered metabolic effects of trehalose on the liver proteome in apoE-knockout mice model of liver steatosis
5. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth
6. Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients
7. Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease
8. Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats
9. Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform
10. Dual-layer spectral-detector CT for detecting liver steatosis by using proton density fat fraction as reference
11. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial
12. Do iron homeostasis biomarkers mediate the associations of liability to type 2 diabetes and glycemic traits in liver steatosis and cirrhosis: a two-step Mendelian randomization study
13. Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men
14. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
15. Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease
16. Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation
17. Kidney and liver fat accumulation: from imaging to clinical consequences
18. Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation
19. Associations of dietary advanced glycation end products with liver steatosis via vibration controlled transient elastography in the United States: a nationwide cross-sectional study
20. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study
21. Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis
22. Heme Oxygenase-1-Modified BMMSCs Activate AMPK–Nrf2–FTH1 to Reduce Severe Steatotic Liver Ischemia–Reperfusion Injury
23. Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application
24. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
25. The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
26. High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
27. Association between hypertension and the prevalence of liver steatosis and fibrosis
28. Towards precision medicine in non-alcoholic fatty liver disease
29. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study
30. Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C
31. Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis
32. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery
33. Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models
34. Hepatocyte-derived MANF mitigates ethanol-induced liver steatosis in mice via enhancing ASS1 activity and activating AMPK pathway
35. NAFLD as the metabolic hallmark of obesity
36. Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study
37. NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study
38. The effect of the skin–liver capsule distance on the accuracy of ultrasound diagnosis for liver steatosis and fibrosis
39. Clinical Relevance of Selenium with Liver Stiffness and Steatosis Detected by Transient Elastography in Adults
40. Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
41. Clinical relevance of environmental manganese exposure with liver stiffness and steatosis detected by transient elastography in adults
42. Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged ≥ 40 years
43. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors
44. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis
45. Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up
46. Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats
47. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease
48. Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
49. Long-term intake of 9-PAHPA or 9-OAHPA modulates favorably the basal metabolism and exerts an insulin sensitizing effect in obesogenic diet-fed mice
50. Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.